Mental Health 360 – Genomind’s Genetic Test Offerings
Learn about Genomind’s two genetic tests, the Professional PGx Express™ and the Mental Health Map™, and how they embody the Mental Health 360™.
Integrating Mental Health PGx into Your Practice: Meet the Experts
Genomind and our panel of experts discuss the importance of integrating mental health PGx testing into your practice.
Beyond One Size Fits All: Using Pharmacogenetics to Improve Antidepressant Efficacy & Tolerability in Children & Adolescents
Genomind and guest speaker, Dr. Jeffrey R. Strawn, MD, FAACP, present Beyond One Size Fits All: Using Pharmacogenetics to Improve Antidepressant Efficacy and Tolerability in Children and Adolescents.
Pharmacogenetics Predictors of Methylphenidate Efficacy in Childhood ADHD
Review pharmacodynamic literature in an effort to identify clinically significant predictors of methylphenidate (MPH) response in children.
Pharmacogenetic-Informed Prescribing in Mental Health Care
Genomind and guest speaker, Dr. Chad Bousman, PhD, MPH, present pharmacogenetic-informed prescribing in mental health care.
Telepsychiatry in the Era of COVID-19
Genomind and guest speakers, Dr. Jay Fawver, Dr. Peter Yellowlees, and Jacob Harper, JD, discuss increasingly relevant topics such as how to transition to telepsychiatry in the age of COVID-19.
